A new 5,698-patient real-world cohort from Valladolid (Del Río-Solá et al., Adv Wound Care 2026) reports 61.8% five-year survival overall, falling to 32.1% after major amputation — and concludes the diabetic foot ulcer should be treated as a marker of advanced systemic disease, not an isolated wound. The newest entry in a fifteen-year line of evidence putting DFU mortality squarely in the cancer conversation.
Outcomes after minor lower limb amputation for peripheral arterial disease and diabetes: population-based cohort study #ActAgainstAmputation @ALPSlimb @BJSurgery
Strong work from our colleagues in Hull, Stoke, and London. These data line up well with previous works from our team and others. Published in: British Journal of Surgery Date of Publication: 22 May 2023 This study aimed to evaluate the rates of re-amputation and death following an initial minor amputation among patients with diabetes... Continue Reading →
Global mortality of diabetic foot ulcer: a systematic review and meta‐analysis of observational studies- nearly 50% 5 year mortality @alpslimb #ActAgainstAmputation
Global mortality of diabetic foot ulcer: a systematic review and meta-analysis of observational studies Compelling work from Chen and coworkers Aims Diabetic foot ulcer (DFU) is an important cause of morbidity, disability, and mortality. However, there was no comprehensive quantitative data on mortality worldwide. The aim of this study was to estimate the long-term mortality... Continue Reading →